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Background: In settler societies such as Australia, Canada, New Zealand and the United States, health inequities
drive lower health status and poorer health outcomes in Indigenous populations. This research unravels the dense
complexity of how historical policy decisions in Canada can influence inequities in health care access in the 21st
century through a case study on the diagnosis and treatment of obstructive sleep apnea (OSA). In Canada, historically
rooted policy regimes determine current discrepancies in health care policy, and in turn, shape current health
insurance coverage and physician decisions in terms of diagnosis and treatment of OSA, a clinical condition that
is associated with considerable morbidity in Canada.
Methods: This qualitative study was based in Saskatchewan, a Western Canadian province which has proportionately
one of the largest provincial populations of an Indigenous subpopulation (status Indians) which is the focus of this
study. The study began with determining approaches to OSA care provision based on Canadian Thoracic Society
guidelines for referral, diagnosis and treatment of sleep disordered breathing. Thereafter, health policy determining
health benefits coverage and program differences between status Indians and other Canadians were ascertained.
Finally, respirologists who specialized in sleep medicine were interviewed. All interviews were audio-recorded and the
transcripts were thematically analyzed using NVIVO.
Results: In terms of access and provision of OSA care, different patient pathways emerged for status Indians in
comparison with other Canadians. Using Saskatchewan as a case study, the preliminary evidence suggests that
status Indians face significant barriers in accessing diagnostic and treatment services for OSA in a timely manner.
Conclusions: In order to confirm initial findings, further investigations are required in other Canadian
jurisdictions. Moreover, as other clinical conditions could share similar features of health care access and provision
of health benefits coverage, this policy analysis could be replicated in other provincial and territorial health care
systems across Canada, and other settler nations where there are differential health coverage arrangements for
Indigenous peoples.
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The Human Development Index consistently ranks Canada
within the top five countries in the world, however,
when the same methodology was modified and applied
to Indigenous Peoples in Canada, they were placed at
the 63rd rank [1]. This gap resonates across the world,
particularly in settler societies such as Australia, Canada,
New Zealand and the United States, where Indigenous
populations have lower health status and poorer health
outcomes than majority populations [2]. While the causal-
ity for this phenomenon is complex, thus far the focus of
research has been on determinants outside of the health
care systems [3]. We have set out to investigate how his-
torically rooted policy regimes determine current discrep-
ancies in health care policy, and in turn how current
health care policy drives health insurance coverage and
physician decisions in terms of diagnosis and treatment.
Canada is divided into ten provinces and three terri-
tories, and health care in Canada is chiefly within the
constitutional authority and responsibility of the provin-
cial and territorial governments [4], with the federal gov-
ernment providing some standards for full coverage of
medically necessary health services commonly known as
Medicare [5]. Nevertheless, although provinces and ter-
ritories are required to provide health services to their
respective residents, significant health care access chal-
lenges exist for Indigenous residents of Canada.
During the period of European colonization of North
America, the British Crown established a number of
treaties with the some Indigenous groups of present day
Canada [6]. Among those treaties, Treaty 6 includes a
clause that states that all necessary medicine will be
made available to those Indigenous groups and their de-
scendants who signed the treaties in exchange for the
surrender of vast land areas. With the Constitution Act
declaring the formation of the Canadian Confederation
under the British Monarchy [7], historically, some court
decisions, and almost all Indigenous organizations and
governments, have interpreted the clause in Treaty 6 as
the federal government of Canada’s responsibility for pro-
viding health services to Indigenous Peoples [8]. However,
since the provision of health services is a provincial and
territorial responsibility in Canada, the health care cover-
age of many Indigenous citizens in Canada remains an am-
biguous and inconclusive area of health care in Canada.
To further complicate this confusing status quo, the
Canadian federal government classifies Indigenous Peo-
ples based on their registration under the federal Indian
Act [7]. Indigenous Peoples who are registered under
this Act are classified as status Indians and those who
are not registered are classified as non-status Indians
[9]. Although the Indian Act itself is widely controversial
and is considered to be a law that limits access to services
and benefits for Indigenous peoples [9], the focus of thisstudy is the exploration of status Indians’ access to diag-
nostic and treatment services.
Currently status Indians are entitled to receive full
Medicare benefits as provincial residents; however, there
exists a discrepancy when providing health care coverage
for “extended health benefits”. Extended health benefits
are all health services that are typically not covered by
Medicare. In essence, unlike all other provincial resi-
dents whose coverage for extended health benefits is
governed by provincial program benefits, status Indians
are ineligible for provincial coverage. Instead they receive
extended health benefits through the federally provided
Non-Insured Health Benefits Program (NIHB). Apart
from status Indians, Inuit populations are also eligible for
NIHB. The Inuit traditionally lived above the tree line of
current day Canada, and are part of a larger circumpolar
Inuit population that includes Greenland, Alaska, and
Russia [9, 10].
As status Indians and recognized Inuit receive ex-
tended benefits through NIHB, according to latest esti-
mates, 925,000 status Indians and recognized Inuit
(roughly 3 % of the Canadian population) are disquali-
fied from receiving coverage through provincial and
territorial extended health coverage laws and regula-
tions [11]. The result is that in 13 different Canadian
jurisdictions (i.e., 10 provinces and 3 territories) status
Indians and recognized Inuit have different extended
health coverage and conditions in comparison with other
provincial and territorial residents. However, when it
comes to Medicare, which includes medically necessary
physician and hospital services, status Indians and
recognized Inuit are treated no differently than all other
provincial and territorial residents because the federal
government insists that provincial governments provide
such coverage in return for federal cash transfers for the
financing of Medicare [5].
This bifurcation of extended health benefits coverage
could influence physician decisions in terms of diagnos-
tic and treatment approaches, and these physician deci-
sions could lead to inequities in terms of disparities in
access between status Indians and other Canadians in
all 13 Canadian jurisdictions. To test this hypothesis,
we identified a health condition that is associated with
considerable morbidity in the Canadian population, and
that requires extended health benefits coverage– obstruct-
ive sleep apnea (OSA).
OSA is the most common type of sleep apnea and
manifests from blockage or collapse of the airways dur-
ing sleep, thus causing episodes of apnea or hypopnea.
Attempts at breathing during these episodes usually re-
sults in snoring, and overall, the condition is associated
with poor sleep quality and excessive daytime sleepiness
[12]. According to the Public Health Agency of Canada,
an estimated 3 % (or approximately 850,000) of Canadian
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more than 25 % of the Canadian adult population is esti-
mated to be undiagnosed sufferers of the condition [13].
While OSA prevalence rates in the Indigenous popu-
lations are currently unavailable, it may be the case that
the condition is more common among these groups
due to experiences of poorer living conditions and
lower socioeconomic status [14]. Indeed, previous research
in the United States and Northern British Columbia iden-
tified a higher prevalence of low quality sleep among indi-
viduals of Indigenous descent [15, 16]. Moreover, OSA is
associated with co-morbid conditions such as cardio-
vascular disease, diabetes, asthma, stroke, and meta-
bolic syndrome and its components [17]. OSA is also
associated with higher risk of motor vehicle accidents
[18], low productivity due to excessive daytime sleepi-
ness [19], and increased healthcare utilization patterns
[20]. These associations of OSA with poor health out-
comes places Indigenous individuals suffering from this
condition at a higher risk of morbidity and mortality.
Studies of high-income countries indicate a consist-
ently higher prevalence of OSA and sleep conditions in
Indigenous and minority groups [21]. For example, the
Maori people of New Zealand have been identified as
having greater prevalence of insomnia, OSA symptoms
and excessive sleepiness; greater severity of OSA symp-
toms; and poorer compliance with treatment compared
to non-Maori people [21–25]. Similarly, in the United
States, a study of older Medicare beneficiaries found
greater sleepiness in non-Caucasian participants than
their Caucasian counterparts [26].
In Canada, New Zealand and other countries, Indigenous
populations’ over-represententation in lower socioeconomic
groups [21, 23] could lead to potential access issues to spe-
cialized treatment and diagnostic services for sleep disor-
ders and other respiratory conditions [22, 23, 27–29].
In this study we first explored health coverage discrep-
ancies for OSA between status Indians and other residents
in the Canadian prairie province of Saskatchewan (Inuit
were excluded from this study because their traditional
homelands are in the territories north of Saskatchewan).
Thereafter, we delineated current Canadian and American
diagnostic and treatment guidelines for OSA. Finally, we
aimed to understand how health coverage and diagnostic
and treatment guidelines for OSA influence physician de-
cision making through interviews with respirologists
based in Saskatchewan. Ultimately, this research is aimed
to unravel the dense complexity of how historical policy
decisions in a settler nation can influence inequities in
health care access in the 21st century.
Methods
This qualitative study began with an extensive review of
the secondary and the grey literature. First, CanadianThoracic Society guidelines for referral, diagnosis and
treatment of sleep disordered breathing were identified
(Table 1). Thereafter, based on these guidelines, ap-
proaches to provision of care to patients with OSA were
delineated. Finally, policy and program differences be-
tween the Saskatchewan government’s extended health
benefits program and the federal government’s NIHB
program in terms of providing care to patients with
OSA were ascertained.
This appraisal of current evidence was an integral
part of the study methodology as it determined the path
of inquiry to understand the intertwined policy and
practice complexities of providing OSA care, including
identifying and interviewing ten key informants. These
key informants involved four Saskatchewan government
extended benefit administrators, three federal govern-
ment NIHB administrators and non-physician service
providers, and three out of six respirologists in the
province of Saskatchewan who specialize in sleep medi-
cine care.
The inclusion criterion for the government adminis-
trators was their direct experience with the provincial
or federal coverage policies and procedures related to
OSA. The inclusion criteria for the respirologists in-
cluded their specialization in sleep medicine and their
current clinical practice in a publicly funded sleep clinic
with a comprehensive sleep laboratory to test, diagnose
and treat all Saskatchewan residents, including status
Indians.
Ethics approval for this study was obtained from re-
search ethics boards at the University of Regina and the
University of Saskatchewan. Thereafter, informed con-
sent for semi-structured interviews was obtained from
all ten key informants. Interviews ranged from 25 to
75 minutes in length. With the exception of one inter-
view conducted by telephone, all key informant inter-
views were conducted in-person. All interviews were
audio-recorded and transcribed verbatim. Each partici-
pant received a transcribed version of their interview
and was asked to review the content to ensure accuracy.
At this point, each participant was given the option to
withdraw the interview or any portion thereof based on
the terms of the ethical consent agreement.
This study specifically focused on the perspectives of
the three respirologists. The interview questions aimed
to capture the complete cycle of provision of care to pa-
tients with OSA, and discern differential access to care
between status Indians and other Canadians. The inter-
view guide consisted of questions such as “On average,
in a week, how often do you see patients in your office
for the purpose of sleep-disordered breathing and/or
OSA?”; “Are there common characteristics that you have
observed in the OSA patient population that you treat,
in terms of age, sex, weight, cultural background, or
Table 1 Canadian thoracic society guidelines for the treatment and diagnosis of obstructive sleep apnea-hypopnea syndrome
Diagnostic Criteria Referral Testing Recommendation
Individual must fulfill criterion A or B,
plus C (level of evidence D).
A. All patients who have suspected sleep-disordered
breathing (SDB) should complete an assessment of
daytime sleepiness such as the Epworth sleepiness
scale (ESS) questionnaire to subjectively assess the
degree of pre-treatment sleepiness.
Level I (complete laboratory polysomnography)
remains the accepted standard for evaluation of
SDB and is the test of choice (level of evidence C).
However, a 2010 joint position paper from the
Canadian Sleep Society and the Canadian Thoracic
Society recommends the use of portable monitoring
testing in three generalized settings for suspected
sleep apnea in uncomplicated patients
(i.e. without comorbidities) [37].
A. Excessive daytime sleepiness that
is not better explained by other
factors.
B. Patient referrals for assessment of SDB should be
physician generated and should provide sufficient
information to be able to determine the urgency of
assessment.
B. Two or more of the following that
are not better explained by other
factors:
C. Patients referred for medical specialist assessment
and/or polysomnography should be triaged by the
categories and criteria listed below.
Priority 1 (Urgent): Patients with suspected SDB and
major daytime sleepiness (ESS of 15 or greater) and
a safety critical occupationa or patients with
suspected SDB and a comorbid diseaseb or overnight
home oximetry that reveals greater than 30 oxygen
desaturations (4 % or greater) per hour.
1. Areas with acceptable wait times for a sleep
medicine consultation and Level 1 sleep study.
1. Choking or gasping during sleep;
2. Areas where the prevalence of Level 1 laboratory
and sleep specialists are limited and the waiting
times are excessive.
2. Recurrent awakenings from sleep;
3. Primarily rural areas, where sleep medicine
specialists and Level 1 testing are not available, and
where general practitioners (including nurse
practitioners under the signing name of a physician)
are the primary caregivers.Priority 2: Patients with suspected SDB and major
daytime sleepiness (ESS of 15 or greater) but without
a safety critical occupation.
3. Unrefreshing sleep; Priority 3: Patients with suspected SDB but without:
major daytime sleepiness (i.e., ESS of 15 or greater),
comorbid diseases, or a safety critical occupation.4. Daytime fatigue; and
Further recommendations and principles regarding
the use of portable monitoring testing, including
the accreditation of portable monitoring programs
and technical and interpretation considerations are
detailed in the joint position paper.
5. Impaired concentration. Waiting times: Medical specialist assessment and/or
polysomnography should be arranged and
completed by the following times after referral
(level of evidence D):
C. Sleep monitoring demonstrates
five or more obstructive apneas/
hypopneas per hour during sleep.
• Priority 1 (urgent) cases – within two to four weeks;
• Priority 2 cases – within two months; and
• Priority 3 cases – within six months.
aSafety critical occupations or at high risk for a motor vehicle collision
bIschemic heart disease, cerebrovascular disease, congestive heart failure, refractory systemic hypertension, obstructive/restrictive lung disease, pulmonary
hypertension or hypercapnic respiratory failure, or pregnancy
Sources: [30, 50]
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changes in medical practice or health policy would make
a significant impact on reducing the health impact of ob-
structive sleep apnea and sleep disordered breathing in
Saskatchewan?”; “Are there specific actions or changes
in medical practice or policy that would make a signifi-
cant impact on OSA in Indigenous populations?” The-
matic analysis was then conducted on the transcripts
using NVIVO software and indicative coding techniques.
The study results are a combination of evidence from
secondary review of existing differences in extended
health benefits coverage between status Indians and
other Canadians, and emerging themes of physician de-
cisions in terms of diagnosis and treatment of OSA.
Results and Discussion
Clinical diagnosis and treatment of obstructive sleep
apnea
The Canadian Thoracic Society’s guidelines (Table 1) clearly
indicate the referral, diagnosis and treatment protocols forOSA [30]. The diagnostic gold standard is a complete, level
1 polysomnography conducted in a specialized sleep labora-
tory. Patients are triaged to undergo polysomnography
according to varying priority levels, thus resulting in waiting
periods that range from two weeks to six months. The al-
ternative to polysomnography is a level 3 home study,
which involves the use of diagnostic equipment in the pa-
tient’s home and thus eliminates the waiting period. While
lacking the specificity of polysomnography, a level 3 home
study typically can diagnose the most common forms of
OSA much more rapidly and at much lower cost.
Upon establishing an OSA diagnosis, the American
College of Physicians recommends continuous positive
airway pressure (CPAP) as the first course of treatment
[31]. CPAP machine is a take-home system that re-
quires the patient to wear a mask during sleep and de-
livers constant pressure flow to ensure the patient’s
airway is maintained throughout the night. While CPAP
is most commonly prescribed, adherence to CPAP
treatment is a widely recognized issue and could result
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treatment inconsistency [32].OSA patient pathways
Figure 1 illustrates the potential OSA patient pathways in
the health care system from the point of first patient-
physician contact to diagnosis and treatment. Figure 1 also
depicts the estimation of relative timeline difference in ac-
cess to care between various pathways. Patients seeking
care are first assessed by family physicians and if suspected
to have OSA, are referred for consultation with respirolo-
gists specializing in sleep medicine. Health care until thisFig. 1 Patient pathways for obstructive sleep apnea diagnostic and treatm
sleep apnea may decide to forego public coverage provided through NIHB
respiratory equipment providerpoint is provided by free provincial universally insured ser-
vices to all residents, including status Indians.
However, after this stage, OSA care is provided through
extended health benefits programs. Thus, provision of
OSA care lies in a grey zone, with initial care (family phys-
ician and respirologist consultation) being provided
through provincial Medicare plans and subsequent care
(diagnosis and treatment) being provided through extended
health benefits programs. In Saskatchewan, all residents ex-
cept status Indians receive extended health care benefits
through the provincial government’s Saskatchewan Aids to
Independent Living (SAIL) program. As enumerated in the
literature review, status Indians receive extended healthent services in Saskatchewan. Note: Upon diagnosis, a patient with
or SAIL and instead purchase a CPAP machine directly form a private
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[33–36].
This separation of extended health benefits provision
results in two distinct patient pathways. SAIL recipients
(i.e., provincial residents other than status Indians) have
shorter waiting periods as they have the choice of either
level 1 polysomnography or level 3 portable monitoring
for testing, and upon diagnosis, are eligible for CPAP
coverage.
Based on existing policy documents, status Indians re-
ceiving extended health benefits through federally ad-
ministered NIHB program incur considerably longer
waiting periods, from initial testing and diagnosis to
obtaining CPAP machines for treatment. This longer
timeline for accessing care is the result of multilevel
health inequities negatively influencing the health of sta-
tus Indians. First, due to existing NIHB extended cover-
age policy, status Indians do not appear to have had the
choice of level 3 monitoring for OSA diagnosis. Thus,
they have to wait an average of 2 to 6 months to
undergo level 1 polysomnography. Next, after diagnosis,
status Indians are only eligible to rent CPAP machines
initially through the NIHB program. NIHB requires pa-
tients to complete a 3-month CPAP rental period and
provide proof of adherence to CPAP therapy before in-
suring CPAP purchase by status Indians. Finally, as there
is evidence of adherence difficulties with CPAP treat-
ment [34], accessing care for OSA through NIHB creates
considerable barriers for status Indians. More specific
differences in CPAP coverage conditions between SAIL
and NIHB are further summarized in Table 2 [37–40].
Provider perspectives
Provider perspectives were probed in interviews with
Saskatchewan-based respirologists practicing sleep medi-
cine and whose practices involved both level 1 and level 3
diagnostic testing for Saskatchewan residents, includ-
ing status Indians. At the time of the study, the three
sleep medicine specialists located in Saskatoon wereTable 2 Coverage for CPAP machine including repairs and accessor
Residents (except status Indians): SAIL
CPAP machine Free loan to patient on recommendation of respiro
(required level of testing not specified)
CPAP repairs Machine returned to SAIL depot in Saskatoon:
free except for shipping costs
Mask No coverage provideda
Headgear No coverage provideda
Tubing No coverage provideda
Humidifier No coverage provideda
aAdditional coverage for these consumable supplies is available on a prior approva
Health Coverage Program through Saskatchewan Health
Sources: [33, 38]responsible for diagnosing and treating patients through-
out Saskatchewan, a geographically expansive province
with a significant percentage of its roughly 1 million resi-
dents living in rural and remote areas. While all respirolo-
gists provide services to status Indian patients, the
proportion of status Indians accessing OSA care seemed
lower in relation to the rest of the provincial population.
The three respirologists described that for every 15 to
20 patients who accessed the sleep lab, only 1 patient
was status Indian, a proportion that is significantly below
the 12.8 % of the provincial population (i.e., status In-
dians) who are deemed to be NIHB eligible clients by
the federal government. In the words on one specialist,
“there are less people referred to the sleep lab or to my
office who are Status Registered Indian compared to
non-Registered Indian. So my gut feeling, and I've not
specifically done this research, but my gut feeling is
they're not proportionally represented in either my office
or the sleep lab compared to what the provincial popula-
tion proportion should be”. One interesting result is that
all three specialists initially felt that they did not treat
patients any differently based on status and rejected any
notion that they would treat patients differently based
on ethnic origin or the terms of public or private cover-
age. At the same time, they all admitted that the admin-
istrative and coverage differences under NIHB could
potentially produce at least some differences in their pat-
terns of practice.
However, in thinking about the conundrum facing
their patients, physicians did admit that approaches in
dealing with status Indians was dictated in a more sig-
nificant manner by the mode of coverage. One physician,
when first asked whether his recommendation depended
on the status of his patients, he stated that he did not
treat his patients differently depending on the source of
their coverage. However, upon reflection, he further re-
versed his earlier statement.
He went to say, “no actually, you know what? That’s
not true. I’m going to withdraw that statement and theies for Saskatchewan residents
Status Indians residents: NIHB
logist Purchase covered on recommendation of physician after
Level 1 test and proof of adherence after 3-month CPAP
rental period
Coverage provided; however prior approval is required
if warranty on device has expired.
Covered upon prior approval
Covered upon prior approval
Covered upon prior approval
Covered upon prior approval
l basis to those patients who qualify for the income-based Supplementary
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funded for a CPAP machine if I send them for Level 3
testing, regardless who’s providing it, right? So I actually
preferentially send people with a Treaty number (status
Indian registration) for Level 1 polysomnography be-
cause I know that it’s going to be an administrative mess
for them to try and get a CPAP machine if I don’t do
that. It’s just a way of facilitating care for them.”
Another physician provided this answer to the same
question, “My recommendation wouldn't vary, but as
you know, because of Ottawa [the federal government],
they want to have a Level 1 study done. So, does that
affect how we care for people? Yeah, you have to do a
level 1 study. Because of that policy, yes. And let's be
honest. If they're from La Ronge (Northern Saskatch-
ewan), it has nothing to do with if they're Status or not
Status. It's a long long drive. If they're from Saskatoon,
however, somebody who is Status versus someone who
is non-Status, everything else being equal, they're going
to have a longer wait because they have to wait for
PSG.”
There was convergence among the three specialists on
one key point. All agreed that, given existing times and
the high public cost of Level 1 testing, Level 3 testing
was a reasonable alternative, a school of thought that
aligns with current diagnostic evidence [41]. All felt that,
despite the evidence supporting this position for the ma-
jority of potential OSA patients, the federal government
had not changed its administrative position. Moreover,
while there was good reason to insist on adherence, two
out of three respirologists felt that patient adherence to
guidelines could be better supported through means
other than using the threat of refusing treatment unless
adherence was demonstrated – in other words, by
treating status Indians the same as they would other
Saskatchewan residents.
One physician summed up the issue surrounding ad-
herence this way, “The First Nations group – at least the
Treaty, you know, I guess I’m going to be specific here
but the individuals with a Treaty number – are the only
group where there’s some kind of deliverable attached to
it, where they have to have used it a certain amount of
time in order to get, or continue to use a machine. That
doesn’t exist for other patients in Saskatchewan who use
CPAP that’s provided by the payer – by Medicare – and
it certainly wouldn’t exist for people who have gone out
and bought their own CPAP machine, which is the other
group. Not a very big group but it does exist.”
The findings from physician interviews validate the re-
sults from the review of diagnostic and treatment guide-
lines for OSA, and extended health benefits coverage.
The current discrepancy in policy between the federal
and Saskatchewan government’s extended health bene-
fits for OSA care further perpetuates entrenched healthinequities in terms of access to health care services.
This discrepancy was encapsulated and a probable solu-
tion was suggested by one physician in this way: “You
know, with respect to the First Nations community in
particular, the goal of care of a person with a Treaty
number – if you look at the big picture of, you know,
“what is the federal government and the provincial gov-
ernment - what are they supposed to do here?” is that
that person’s supposed to get treated the same way as
any other resident of their community with respect to
health care. So, in Saskatchewan, that would mean that
they would have more timely access to a CPAP ma-
chine. Like I can write, I can get one for a patient, for
example in the sleep lab, they get one same day of their
assessment as long as they don’t have a Treaty number.
If they have a Treaty number, I have to send them to a
vendor and then they have to borrow a machine for a
while and then they have to prove they’re using it and
then… you know? There’s often big gaps for these
people in terms of timely treatment. Sometimes much
longer than you might expect – sometimes weeks and
sometimes months. So a change where that, you know… it
could be very simple. There’s a simple solution here – that
SAIL (pardon me - Saskatchewan Aids to Independent
Living) takes on the role of providing that to the First
Nations community and then bills NIHB or invoices them
or however you wanted to do that”.
In summary, the two major difficulties faced by the sta-
tus Indian populations living on reserves in Saskatchewan
[42] are geographic distances to the only two publicly
funded sleep clinics (located in Saskatoon and Regina) and
the mandatory level 1 polysomnography resulting in
wait times of over a year due to the limited availability
of sleep clinics in Saskatchewan [43]. The multi-level
barriers to access to care could contribute to the under-
representation of status Indians’ in sleep clinics, as
described by the respirologists. This underrepresenta-
tion has wider implications in underestimating the
prevalence of OSA among status Indians and as a con-
sequence increases their risk of morbidity and mortality
from comorbidities of OSA [12, 44–46]. With status In-
dians already suffering from higher prevalence of co-
morbidities of OSA [5, 47–49], an underestimation of
OSA prevalence is indicative of how policy-driven
health inequities can further widen existing health in-
equalities in disadvantaged populations.
Limitations and strengths
While the interviews clearly reflected the view that sta-
tus Indians were under-represented relative to the ma-
jority population in terms of the diagnosis and treatment
of OSA, this qualitative research cannot establish that
current policy is linked to the underestimation of OSA
prevalence in status Indians in Saskatchewan. Moreover,
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and although clear patterns of disparities in coverage
emerged, the findings can only be generalized to provinces
with similar extended health benefits policy regimes.
Nevertheless, this study is a novel investigation exploring
policy driven practice that has implications not only for
OSA patient care, but also for other clinical conditions
that share similar features of lying at the boundary be-
tween universal Medicare coverage and the more frag-
mented systems of extended health benefit coverage
across Canada.
Conclusions
OSA is serious public health issue affecting all Canadians;
however in Saskatchewan, considerably greater barriers
faced by status Indians in accessing OSA care could ultim-
ately influence underestimation of OSA prevalence in
these populations. To understand if the implementation
of federal government’s NIHB program in 13 sub-state
jurisdictional settings in Canada in terms of providing
OSA care coverage can differ depending on the configur-
ation of provincial and territorial extended benefits pro-
grams, a more comprehensive study spanning all
Canadian jurisdictions is necessary. However, before con-
ceptualizing a complex cross-Canadian study, it is impera-
tive to validate current findings with a longitudinal cohort
study that compares not only access to OSA care, but also
adherence to OSA treatment and clinical outcomes be-
tween status Indians and other residents in Saskatchewan.
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